ARKEMA (AKE.PA) Fundamental Analysis & Valuation

EPA:AKE • FR0010313833

Current stock price

61.9 EUR
+0.3 (+0.49%)
Last:

This AKE.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. AKE.PA Profitability Analysis

1.1 Basic Checks

  • In the past year AKE was profitable.
  • AKE had a positive operating cash flow in the past year.
  • AKE had positive earnings in each of the past 5 years.
  • AKE had a positive operating cash flow in each of the past 5 years.
AKE.PA Yearly Net Income VS EBIT VS OCF VS FCFAKE.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B

1.2 Ratios

  • AKE has a Return On Assets (0.27%) which is in line with its industry peers.
  • AKE has a Return On Equity (0.57%) which is in line with its industry peers.
  • AKE's Return On Invested Capital of 1.90% is in line compared to the rest of the industry. AKE outperforms 43.48% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for AKE is below the industry average of 6.97%.
Industry RankSector Rank
ROA 0.27%
ROE 0.57%
ROIC 1.9%
ROA(3y)1.76%
ROA(5y)4.56%
ROE(3y)3.55%
ROE(5y)8.83%
ROIC(3y)2.66%
ROIC(5y)4.13%
AKE.PA Yearly ROA, ROE, ROICAKE.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

  • AKE has a Profit Margin (0.43%) which is comparable to the rest of the industry.
  • In the last couple of years the Profit Margin of AKE has declined.
  • With a Operating Margin value of 4.63%, AKE perfoms like the industry average, outperforming 44.93% of the companies in the same industry.
  • In the last couple of years the Operating Margin of AKE has declined.
  • The Gross Margin of AKE (17.80%) is worse than 73.91% of its industry peers.
  • AKE's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 4.63%
PM (TTM) 0.43%
GM 17.8%
OM growth 3Y-28.32%
OM growth 5Y-8.39%
PM growth 3Y-62.59%
PM growth 5Y-35.51%
GM growth 3Y-7.29%
GM growth 5Y-1.94%
AKE.PA Yearly Profit, Operating, Gross MarginsAKE.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

4

2. AKE.PA Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so AKE is destroying value.
  • Compared to 1 year ago, AKE has less shares outstanding
  • The number of shares outstanding for AKE has been reduced compared to 5 years ago.
  • Compared to 1 year ago, AKE has a worse debt to assets ratio.
AKE.PA Yearly Shares OutstandingAKE.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
AKE.PA Yearly Total Debt VS Total AssetsAKE.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.2 Solvency

  • Based on the Altman-Z score of 1.76, we must say that AKE is in the distress zone and has some risk of bankruptcy.
  • AKE has a Altman-Z score of 1.76. This is in the lower half of the industry: AKE underperforms 71.01% of its industry peers.
  • The Debt to FCF ratio of AKE is 13.85, which is on the high side as it means it would take AKE, 13.85 years of fcf income to pay off all of its debts.
  • AKE has a Debt to FCF ratio (13.85) which is comparable to the rest of the industry.
  • A Debt/Equity ratio of 0.56 indicates that AKE is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.56, AKE is in line with its industry, outperforming 43.48% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF 13.85
Altman-Z 1.76
ROIC/WACC0.41
WACC4.65%
AKE.PA Yearly LT Debt VS Equity VS FCFAKE.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.3 Liquidity

  • A Current Ratio of 2.13 indicates that AKE has no problem at all paying its short term obligations.
  • AKE has a better Current ratio (2.13) than 69.57% of its industry peers.
  • A Quick Ratio of 1.63 indicates that AKE should not have too much problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 1.63, AKE is in the better half of the industry, outperforming 78.26% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.13
Quick Ratio 1.63
AKE.PA Yearly Current Assets VS Current LiabilitesAKE.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

3

3. AKE.PA Growth Analysis

3.1 Past

  • The earnings per share for AKE have decreased strongly by -47.50% in the last year.
  • The Earnings Per Share has been decreasing by -3.31% on average over the past years.
  • Looking at the last year, AKE shows a decrease in Revenue. The Revenue has decreased by -4.99% in the last year.
  • AKE shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.84% yearly.
EPS 1Y (TTM)-47.5%
EPS 3Y-34.91%
EPS 5Y-3.31%
EPS Q2Q%-66.14%
Revenue 1Y (TTM)-4.99%
Revenue growth 3Y-7.75%
Revenue growth 5Y2.84%
Sales Q2Q%-7.39%

3.2 Future

  • AKE is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.99% yearly.
  • AKE is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.68% yearly.
EPS Next Y10.82%
EPS Next 2Y15.19%
EPS Next 3Y15.67%
EPS Next 5Y11.99%
Revenue Next Year1.07%
Revenue Next 2Y1.68%
Revenue Next 3Y1.98%
Revenue Next 5Y2.68%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
AKE.PA Yearly Revenue VS EstimatesAKE.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B 8B 10B
AKE.PA Yearly EPS VS EstimatesAKE.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5 10 15

7

4. AKE.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 14.36, the valuation of AKE can be described as correct.
  • Based on the Price/Earnings ratio, AKE is valued cheaper than 81.16% of the companies in the same industry.
  • AKE's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.79.
  • Based on the Price/Forward Earnings ratio of 12.96, the valuation of AKE can be described as correct.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of AKE indicates a rather cheap valuation: AKE is cheaper than 81.16% of the companies listed in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 38.88. AKE is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 14.36
Fwd PE 12.96
AKE.PA Price Earnings VS Forward Price EarningsAKE.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AKE indicates a rather cheap valuation: AKE is cheaper than 81.16% of the companies listed in the same industry.
  • AKE's Price/Free Cash Flow ratio is rather cheap when compared to the industry. AKE is cheaper than 82.61% of the companies in the same industry.
Industry RankSector Rank
P/FCF 14.31
EV/EBITDA 5.6
AKE.PA Per share dataAKE.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • AKE's earnings are expected to grow with 15.67% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.33
PEG (5Y)N/A
EPS Next 2Y15.19%
EPS Next 3Y15.67%

7

5. AKE.PA Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 5.88%, AKE is a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 2.18, AKE pays a better dividend. On top of this AKE pays more dividend than 94.20% of the companies listed in the same industry.
  • AKE's Dividend Yield is rather good when compared to the S&P500 average which is at 1.81.
Industry RankSector Rank
Dividend Yield 5.88%

5.2 History

  • On average, the dividend of AKE grows each year by 10.37%, which is quite nice.
Dividend Growth(5Y)10.37%
Div Incr Years4
Div Non Decr Years5
AKE.PA Yearly Dividends per shareAKE.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3

5.3 Sustainability

  • 697.44% of the earnings are spent on dividend by AKE. This is not a sustainable payout ratio.
  • The dividend of AKE is growing around the same rate as the earnings are growing. If this keeps up the dividend growth is sustainable.
DP697.44%
EPS Next 2Y15.19%
EPS Next 3Y15.67%
AKE.PA Yearly Income VS Free CF VS DividendAKE.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
AKE.PA Dividend Payout.AKE.PA Dividend Payout, showing the Payout Ratio.AKE.PA Dividend Payout.PayoutRetained Earnings

AKE.PA Fundamentals: All Metrics, Ratios and Statistics

ARKEMA

EPA:AKE (4/22/2026, 7:00:00 PM)

61.9

+0.3 (+0.49%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)02-26
Earnings (Next)05-06
Inst Owners58.04%
Inst Owner ChangeN/A
Ins Owners0.61%
Ins Owner ChangeN/A
Market Cap4.71B
Revenue(TTM)9.07B
Net Income(TTM)39.00M
Analysts72.73
Price Target64.06 (3.49%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.88%
Yearly Dividend3.59
Dividend Growth(5Y)10.37%
DP697.44%
Div Incr Years4
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-24.85%
Min EPS beat(2)-39.37%
Max EPS beat(2)-10.34%
EPS beat(4)0
Avg EPS beat(4)-16.25%
Min EPS beat(4)-39.37%
Max EPS beat(4)-6.61%
EPS beat(8)2
Avg EPS beat(8)-8.47%
EPS beat(12)5
Avg EPS beat(12)-4.27%
EPS beat(16)9
Avg EPS beat(16)3.1%
Revenue beat(2)1
Avg Revenue beat(2)0.01%
Min Revenue beat(2)-1.17%
Max Revenue beat(2)1.2%
Revenue beat(4)1
Avg Revenue beat(4)-0.34%
Min Revenue beat(4)-1.17%
Max Revenue beat(4)1.2%
Revenue beat(8)2
Avg Revenue beat(8)-0.43%
Revenue beat(12)3
Avg Revenue beat(12)-1.01%
Revenue beat(16)7
Avg Revenue beat(16)-0.03%
PT rev (1m)1.07%
PT rev (3m)1.39%
EPS NQ rev (1m)-12.71%
EPS NQ rev (3m)-30.82%
EPS NY rev (1m)-2.95%
EPS NY rev (3m)-4.93%
Revenue NQ rev (1m)0.23%
Revenue NQ rev (3m)0.32%
Revenue NY rev (1m)0.82%
Revenue NY rev (3m)-0.36%
Valuation
Industry RankSector Rank
PE 14.36
Fwd PE 12.96
P/S 0.52
P/FCF 14.31
P/OCF 4.72
P/B 0.69
P/tB 2.56
EV/EBITDA 5.6
EPS(TTM)4.31
EY6.96%
EPS(NY)4.78
Fwd EY7.72%
FCF(TTM)4.33
FCFY6.99%
OCF(TTM)13.11
OCFY21.18%
SpS119.22
BVpS89.97
TBVpS24.14
PEG (NY)1.33
PEG (5Y)N/A
Graham Number93.4061 (50.9%)
Profitability
Industry RankSector Rank
ROA 0.27%
ROE 0.57%
ROCE 3.5%
ROIC 1.9%
ROICexc 2.33%
ROICexgc 4.77%
OM 4.63%
PM (TTM) 0.43%
GM 17.8%
FCFM 3.63%
ROA(3y)1.76%
ROA(5y)4.56%
ROE(3y)3.55%
ROE(5y)8.83%
ROIC(3y)2.66%
ROIC(5y)4.13%
ROICexc(3y)3.19%
ROICexc(5y)5.03%
ROICexgc(3y)6.48%
ROICexgc(5y)9.7%
ROCE(3y)4.96%
ROCE(5y)7.74%
ROICexgc growth 3Y-32.65%
ROICexgc growth 5Y-8.51%
ROICexc growth 3Y-33.65%
ROICexc growth 5Y-10.69%
OM growth 3Y-28.32%
OM growth 5Y-8.39%
PM growth 3Y-62.59%
PM growth 5Y-35.51%
GM growth 3Y-7.29%
GM growth 5Y-1.94%
F-Score6
Asset Turnover0.64
Health
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF 13.85
Debt/EBITDA 3.02
Cap/Depr 79.71%
Cap/Sales 7.37%
Interest Coverage 17.5
Cash Conversion 79.25%
Profit Quality 843.59%
Current Ratio 2.13
Quick Ratio 1.63
Altman-Z 1.76
F-Score6
WACC4.65%
ROIC/WACC0.41
Cap/Depr(3y)89.68%
Cap/Depr(5y)93.13%
Cap/Sales(3y)7.49%
Cap/Sales(5y)7.36%
Profit Quality(3y)365.95%
Profit Quality(5y)238.07%
High Growth Momentum
Growth
EPS 1Y (TTM)-47.5%
EPS 3Y-34.91%
EPS 5Y-3.31%
EPS Q2Q%-66.14%
EPS Next Y10.82%
EPS Next 2Y15.19%
EPS Next 3Y15.67%
EPS Next 5Y11.99%
Revenue 1Y (TTM)-4.99%
Revenue growth 3Y-7.75%
Revenue growth 5Y2.84%
Sales Q2Q%-7.39%
Revenue Next Year1.07%
Revenue Next 2Y1.68%
Revenue Next 3Y1.98%
Revenue Next 5Y2.68%
EBIT growth 1Y-41.5%
EBIT growth 3Y-33.87%
EBIT growth 5Y-5.79%
EBIT Next Year129.39%
EBIT Next 3Y38.89%
EBIT Next 5Y24.49%
FCF growth 1Y-8.61%
FCF growth 3Y-24.55%
FCF growth 5Y-8.39%
OCF growth 1Y-11.06%
OCF growth 3Y-12.65%
OCF growth 5Y-2.21%

ARKEMA / AKE.PA Fundamental Analysis FAQ

What is the fundamental rating for AKE stock?

ChartMill assigns a fundamental rating of 4 / 10 to AKE.PA.


Can you provide the valuation status for ARKEMA?

ChartMill assigns a valuation rating of 7 / 10 to ARKEMA (AKE.PA). This can be considered as Undervalued.


Can you provide the profitability details for ARKEMA?

ARKEMA (AKE.PA) has a profitability rating of 3 / 10.


What are the PE and PB ratios of ARKEMA (AKE.PA) stock?

The Price/Earnings (PE) ratio for ARKEMA (AKE.PA) is 14.36 and the Price/Book (PB) ratio is 0.69.


Can you provide the financial health for AKE stock?

The financial health rating of ARKEMA (AKE.PA) is 4 / 10.